Free Trial

Telomir Pharmaceuticals (TELO) SEC Filings & 10K Form

Telomir Pharmaceuticals logo
$1.68 +0.02 (+0.90%)
As of 11:12 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Telomir Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/07/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
8:15 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
8:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
6:12 AM
Telomir Pharmaceuticals (Issuer)
Weichselbaum Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2025
7:00 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
7:00 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
7:00 PM
Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
7:00 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
4:25 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
7:45 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
6:45 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2025
11:15 PM
Telomir Pharmaceuticals (Filer)
Form EFFECT
02/18/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:05 PM
Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/28/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
6:30 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
6:00 AM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:00 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:01 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
4:06 PM
Bay Shore Trust (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:15 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
12:37 PM
Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:37 PM
Telomir Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:05 PM
Telomir Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/29/2024
3:05 PM
Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
Jerman Michael Allen (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
10:17 AM
Aminov Erez (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
10:17 AM
MacPherson Edward Clouston (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
10:17 AM
Telomir Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
10:17 AM
Del Giudice Matthew Paul (Reporting)
Telomir Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TELO) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners